ARMISTICE CAPITAL, LLC - CRISPR THERAPEUTICS AG ownership

CRISPR THERAPEUTICS AG's ticker is CRSP and the CUSIP is H17182108. A total of 375 filers reported holding CRISPR THERAPEUTICS AG in Q1 2023. The put-call ratio across all filers is 1.09 and the average weighting 0.2%.

Quarter-by-quarter ownership
ARMISTICE CAPITAL, LLC ownership history of CRISPR THERAPEUTICS AG
ValueSharesWeighting
Q3 2023$27,234,545
-3.0%
600,012
+20.0%
0.42%
+2.7%
Q2 2023$28,070,000
-24.7%
500,000
-39.3%
0.41%
-24.4%
Q1 2023$37,269,520
-11.5%
824,000
-20.5%
0.54%
-26.9%
Q4 2022$42,113,400
-30.3%
1,036,000
+12.1%
0.74%
-29.8%
Q3 2022$60,383,000
-0.6%
924,000
-7.6%
1.05%
-1.2%
Q2 2022$60,770,000
-5.5%
1,000,000
-2.3%
1.06%
-14.7%
Q1 2022$64,276,000
-4.9%
1,024,000
+14.8%
1.24%
+12.4%
Q4 2021$67,596,000
+58.9%
892,000
+134.7%
1.11%
+53.6%
Q3 2021$42,533,000
+66.3%
380,000
+140.5%
0.72%
+57.2%
Q2 2021$25,579,000
+34.6%
158,000
+1.3%
0.46%
+5.0%
Q1 2021$19,009,000
+72.4%
156,000
+116.7%
0.44%
+16.3%
Q4 2020$11,024,000
-35.4%
72,000
-64.7%
0.38%
-39.4%
Q3 2020$17,063,000
+23.5%
204,000
+8.5%
0.62%
+2.1%
Q2 2020$13,816,000
+38.0%
188,000
-20.3%
0.61%
-2.1%
Q1 2020$10,009,000
+11.0%
236,000
+59.5%
0.62%
+19.0%
Q4 2019$9,014,000
-16.7%
148,000
-43.9%
0.52%
-27.5%
Q3 2019$10,821,000
+278.6%
264,000
+230.0%
0.72%
+359.6%
Q1 2019$2,858,000
-41.8%
80,000
-53.5%
0.16%
-58.1%
Q4 2018$4,914,000
-32.6%
172,000
+38.7%
0.37%
-21.8%
Q2 2018$7,286,000124,0000.48%
Other shareholders
CRISPR THERAPEUTICS AG shareholders Q1 2023
NameSharesValueWeighting ↓
Versant Venture Management, LLC 498,558$27,989,04633.20%
Gilfoyle Management LLC 100$4,84215.90%
NEA Management Company, LLC 1,587,854$89,142,1246.80%
ARK Investment Management 7,338,447$411,980,3942.73%
Nikko Asset Management Americas, Inc. 3,533,357$198,327,3282.09%
Del-Sette Capital Management, LLC 33,661$1,889,7291.79%
Ikarian Capital, LLC 200,000$11,228,0001.79%
Ikarian Capital, LLC 200,000$11,228,0001.79%
Merlin Capital, Inc 8,802$494,1441.67%
Green Alpha Advisors, LLC 34,373$1,929,7001.27%
View complete list of CRISPR THERAPEUTICS AG shareholders